Articoli con mandati relativi all'accesso pubblico - Bert VogelsteinUlteriori informazioni
TotaleNIHHHMIWellcomeFWFDoDNHMRCDOEEuropean CommissionDoris Duke Charitable FoundationGoverno ItalianoNSFAlex's Lemonade StandMedical Research Future Fund, AustraliaGatesCIHRV Foundation, USASNSFVACCSNSERCDFGCSIRDBTSwedish Research CouncilBMBFKWFNMRCResearch Grants Council, Hong KongLUNGevity Foundation, USADamon Runyon Cancer Research FoundationSusan G. Komen
Non disponibili pubblicamente: 6
Cancer risk: role of environment—response
C Tomasetti, B Vogelstein
Science 347 (6223), 729-731, 2015
Mandati: Howard Hughes Medical Institute
Application of deep learning to pancreatic cancer detection: lessons learned from our initial experience
LC Chu, S Park, S Kawamoto, Y Wang, Y Zhou, W Shen, Z Zhu, Y Xia, ...
Journal of the American College of Radiology 16 (9), 1338-1342, 2019
Mandati: US National Institutes of Health
Spectrum of genetic mutations in de novo PUNLMP of the urinary bladder
MDC Rodriguez Pena, AC Tregnago, ML Eich, S Springer, Y Wang, ...
Virchows Archiv 471, 761-767, 2017
Mandati: US National Institutes of Health
The nuclear matrix and the organization of nuclear DNA
B Vogelstein, D Small, S Robinson, B Nelkin
Progress in nonhistone protein research, 115-129, 2018
Mandati: US National Institutes of Health
Necessity is the mother of invention: the development of digital genomics
K Kinzler, B Vogelstein
Clinical chemistry 62 (12), 1668-1669, 2016
Mandati: US National Institutes of Health, Howard Hughes Medical Institute
Preclinical studies show that Co-STARs combine the advantages of chimeric antigen and T cell receptors for the treatment of tumors with low antigen densities
BJ Mog, N Marcou, SR DiNapoli, AH Pearlman, TD Nichakawade, ...
Science translational medicine 16 (755), eadg7123, 2024
Mandati: Howard Hughes Medical Institute
Disponibili pubblicamente: 221
PD-1 blockade in tumors with mismatch-repair deficiency
DT Le, JN Uram, H Wang, BR Bartlett, H Kemberling, AD Eyring, ...
New England Journal of Medicine 372 (26), 2509-2520, 2015
Mandati: US National Institutes of Health
Cancer genome landscapes
B Vogelstein, N Papadopoulos, VE Velculescu, S Zhou, LA Diaz Jr, ...
science 339 (6127), 1546-1558, 2013
Mandati: US National Institutes of Health, Howard Hughes Medical Institute
An integrated genomic analysis of human glioblastoma multiforme
DW Parsons, S Jones, X Zhang, JCH Lin, RJ Leary, P Angenendt, ...
science 321 (5897), 1807-1812, 2008
Mandati: US National Institutes of Health, Howard Hughes Medical Institute
IDH1 and IDH2 Mutations in Gliomas
H Yan, DW Parsons, G Jin, R McLendon, BA Rasheed, W Yuan, I Kos, ...
New England journal of medicine 360 (8), 765-773, 2009
Mandati: US National Institutes of Health
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
DT Le, JN Durham, KN Smith, H Wang, BR Bartlett, LK Aulakh, S Lu, ...
Science 357 (6349), 409-413, 2017
Mandati: US National Institutes of Health, Howard Hughes Medical Institute
Detection of circulating tumor DNA in early-and late-stage human malignancies
C Bettegowda, M Sausen, RJ Leary, I Kinde, Y Wang, N Agrawal, ...
Science translational medicine 6 (224), 224ra24-224ra24, 2014
Mandati: US National Institutes of Health, Wellcome Trust, Governo Italiano
Core signaling pathways in human pancreatic cancers revealed by global genomic analyses
S Jones, X Zhang, DW Parsons, JCH Lin, RJ Leary, P Angenendt, ...
science 321 (5897), 1801-1806, 2008
Mandati: US National Institutes of Health, Howard Hughes Medical Institute
Circulating mutant DNA to assess tumor dynamics
F Diehl, K Schmidt, MA Choti, K Romans, S Goodman, M Li, K Thornton, ...
Nature medicine 14 (9), 985-990, 2008
Mandati: US National Institutes of Health, Howard Hughes Medical Institute
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
S Yachida, S Jones, I Bozic, T Antal, R Leary, B Fu, M Kamiyama, ...
Nature 467 (7319), 1114-1117, 2010
Mandati: US National Institutes of Health, Howard Hughes Medical Institute
Detection and localization of surgically resectable cancers with a multi-analyte blood test
JD Cohen, L Li, Y Wang, C Thoburn, B Afsari, L Danilova, C Douville, ...
Science 359 (6378), 926-930, 2018
Mandati: US Department of Defense, US National Institutes of Health, Howard Hughes …
Variation in cancer risk among tissues can be explained by the number of stem cell divisions
C Tomasetti, B Vogelstein
Science 347 (6217), 78-81, 2015
Mandati: US National Institutes of Health, Howard Hughes Medical Institute
Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1
N Agrawal, MJ Frederick, CR Pickering, C Bettegowda, K Chang, RJ Li, ...
Science 333 (6046), 1154-1157, 2011
Mandati: US National Institutes of Health, Howard Hughes Medical Institute
The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers
LA Diaz Jr, RT Williams, J Wu, I Kinde, JR Hecht, J Berlin, B Allen, I Bozic, ...
Nature 486 (7404), 537-540, 2012
Mandati: US National Institutes of Health, Howard Hughes Medical Institute, Austrian …
DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors
Y Jiao, C Shi, BH Edil, RF De Wilde, DS Klimstra, A Maitra, RD Schulick, ...
Science 331 (6021), 1199-1203, 2011
Mandati: US National Institutes of Health, Howard Hughes Medical Institute
Le informazioni sulla pubblicazione e sul finanziamento vengono stabilite automaticamente da un software